Tender For Supply Of Kits Chemical Reagents Glassware Etc, Ajmer-Rajasthan

Tender For supply of Kits Chemical Reagents Glassware Etc - 1.Anti-A antisera, Monoclonal blood grouping IgM antibody for slide and tube method For ABO blood groupingVial of 10 ml and storage at +2to +8°C. Titer >1:256 with A cell and negative with B cell.avidity should be 4sec. Should be validated by NIB/EC/AABB/FDA. Demonstration of item is must for final technical approval.2.Anti-B antisera, Monoclonal blood grouping IgM antibody for slide and tube method For ABO blood grouping Vial of 10 ml each and storage at + 2 to 8°C. Titer 1:256 with B cell and negative with A cell. avidity should be 4sec. Should be validated by NIB/EC/AABB/FDA. Demonstration of item is must for final technical approval.Anti-D antisera, IgM and IgG combination, Monoclonal IgM and IgG blood typing antibody for3.Slide and tube method For RH blood typing Vial of 10 ml each and storage at 2 to 8°C. Titre 1:256 with Rh positive cell. avidity should be < 10 sec. Should be validated by NIB/EC/AABB/FDA. Demonstration of item is must for final technical approval.4.Anti-AB antisera, Monoclonal blood grouping IgM antibody for slide and tube method For ABO blood grouping Vial of 10 ml each and storage at + 2 to +8°C. Titer 1:256 with A cell and with B cell. Should be validated by NIR/EC/AABB/FDA. Demonstration of item is must for final technical approval.5.Anti-D antisera, monoclonal IgG only, antibody only for tube method For weak D testing. Titre 1:32 and specificity: 100% to Rho(D antigen). avidity should be <5 sec. Vial of 10 ml each. Should be validated by NIB/EC/AABB/FDA. Demonstration of item is must for final technical approval.6.Anti-Al lectin, monoclonal IgM antibody for tube method To differentiate Al red cell antigen from A2 antigen. Vial of 5 ml cach. Should he validated by NIB/EC/AABB/FDA. Demonstration of item is must for final technical approval.7.Anti-H lectin, monoclonal IgM antibody for tube method Vial of 5ml each and storage of 2 to 8°C. Titre 1:16 with O group cells and negative reaction, 8.Anti-Human Globulin (coombs sera) polyspecific, containing anti-IgG and anti C3d To detect IgG antibodies as in Cross matching, DAT and IAT testsVial of 10 ml each and storage at 2 to 8°C. AHG should give 2+/3+/4+ reaction with Coombs Control Cell and negative reaction with any std cell. Should be validated by NIB/EC/AABB/FDA. Demonstration of item is must for final technical approval.9.Bovine serum Albumin 22% solution for serological applications, protein concentration and pH should be adjusted to 22% and 7.1(+/-0.2%) respectively To enhance immunological reactions and increase test sensitivity. Should be validated by NIB/EC/AABB/FDA. Vial of 10 ml each and storage at 2 to +8°C. Demonstration of item is must for final technical approval.10.Fourth generation ELISA Kit for anti-HCV Microplate coated with recombinant/Synthetic peptide antigens for core NS3, NS4 & NS5 and antibody to HCV Core Antigen.NIV/ WHO GMP qualified sensitivity: ≥ 99.5% and specificity: 99.8% Antibody (IgG and IgM detection. Demonstration of item is must for final technical approval.11.Fourth generation ELISA kit for detection of IIIV p24 antigen & anti-HIV 1/2 antibody. NIV/ WHO GMP qualified sensitivity: ≥ 99.5% and specificity: 99.8% Antibody (IgG and IgM detection).Analytical sensitivity 08 IU/ml for p24 antigen Demonstration of item is must for final technical approval.12.Fourth generation/Third generation ELISA Kit for Hepatitis B Surface Antigen and IgG and IgM detection NIV/ WHO GMP qualified sensitivity299.5% and specificity: 99.8% Antibody (IgG and IgMdetection). Analytical sensitivity <50 picogram/ml Demonstration of item is must for final technical approval.13.Rapid test kits anti-HIV fourth generation for P24 antigen & antibody detection.(Principal of Enzyme Immuno Assay, Agglutination, or any other principal) Should be a solid phase coated HIVI & HIV II recombinant and synthetic peptide antigen and antibody to HIV I P24.Assay should detect HIV I & HIV II Antibodies and HIV I P24 Antigen in plasma, serum or whole Blood.Supplier must provide Negative & Positive control free of cost as and when required by the department. NARI/NIV/ WHO evaluated sensitivity:299.5% and specificity: > 98%. Should be solid phase coated HIV I & HIV II Recombinant and/or synthetic peptide antigens Demonstration of item is must for final technical approval.14.Rapid test Kits for HCV antibody (Should be solid phase/particle coated with recombinant and/or/synthetic peptide antigen for Core. NS3, NS4, NS5) Supplier must provide Negative & Positive control free of cost as and when required by the department. NARI/NIV/ WHO evaluated sensitivity: 99% and specificity: ≥ 98%. Demonstration of item is must for final technical approval., etc.

Sr No	CorrigendumDate	Corrigendum	CorrigendumType	NewSubmissionDate
1	12-06-2025		Modification in BoQ	02-07-2025

Refer document

Refer document

INR 2 Crore /-

FileName	File Description	File Size
Click here to download tender document	Tender Documents	0 KB